Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2009
Date: 2010-03-18
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, European Economic Area, market approval, medicinal product, withdrawal from the market








C_2010067EN.01001201.xml










18.3.2010   


EN


Official Journal of the European Union


C 67/12






Subcommittee I on the free movement of goods


To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2009, at their meeting on 4 December 2009:







Annex I



List of new marketing authorisations





Annex II



List of renewed marketing authorisations





Annex III



List of extended marketing authorisations





Annex IV



List of withdrawn marketing authorisations





Annex V



List of suspended marketing authorisations






ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/08/462/001/NO-006/NO


Ranexa


Norway


4.2.2009




EU/1/08/474/001/NO-003/NO


Alisade


Norway


19.1.2009




EU/1/08/474/001-003/IS


Alisade


Iceland


16.1.2009




EU/1/08/475/001-034


Olanzapin Mylan


Liechtenstein


30.4.2009




EU/1/08/476/001-004/IS


Tadalafil Lilly


Iceland


16.1.2009




EU/1/08/480/001/NO-018/NO


Irbesartan Krka


Norway


17.2.2009




EU/1/08/480/001-018/IS


Irbesartan Krka


Iceland


29.1.2009




EU/1/08/481/001/NO-003/NO


Kuvan


Norway


5.1.2009




EU/1/08/481/001-003/IS


Kuvan


Iceland


25.1.2009




EU/1/08/482/001/NO-002/NO


Azarga


Norway


5.1.2009




EU/1/08/482/001-002/IS


Azarga


Iceland


26.1.2009




EU/1/08/483/001/NO-018/NO


Zomarist


Norway


5.1.2009




EU/1/08/483/001-018/IS


Zomarist


Iceland


16.1.2009




EU/1/08/484/001/NO-018/NO


Icandra


Norway


18.3.2009




EU/1/08/484/001-018/IS


Icandra


Iceland


15.1.2009




EU/1/08/488/001


Vidaza


Liechtenstein


28.2.2009




EU/1/08/488/001/IS


Vidaza


Iceland


15.1.2009




EU/1/08/488/001/NO


Vidaza


Norway


20.1.2009




EU/1/08/489/001


Opgenra


Liechtenstein


28.2.2009




EU/1/08/489/001/NO


Opgenra


Norway


24.3.2009




EU/1/08/489/01/IS


Opgenra


Iceland


25.3.2009




EU/1/08/490/001/NO-016/NO


Pramipexole Teva


Norway


5.2.2009




EU/1/08/490/001-016


Pramipexole Teva


Liechtenstein


28.2.2009




EU/1/08/490/001-016/IS


Pramipexole Teva


Iceland


23.2.2009




EU/1/08/491/001-080


Rasilez HCT


Liechtenstein


28.2.2009




EU/1/08/491/001-080/IS


Rasilez HCT


Iceland


17.3.2009




EU/1/08/492/001/NO-006/NO


RoActemra


Norway


6.2.2009




EU/1/08/492/001-006


RoActemra


Liechtenstein


28.2.2009




EU/1/08/492/001-006/IS


RoActemra


Iceland


18.3.2009




EU/1/08/494/001/NO-002/NO


Stelara


Norway


9.2.2009




EU/1/08/494/001-002


Stelara


Liechtenstein


28.2.2009




EU/1/08/494/001-002/IS


Stelara


Iceland


18.3.2009




EU/1/08/495/001/NO-008/NO


Zarzio


Norway


3.3.2009




EU/1/08/495/001-008


Zarzio


Liechtenstein


28.2.2009




EU/1/08/495/001-008/IS


Zarzio


Iceland


20.3.2009




EU/1/08/496/001/NO-008/NO


Filgrastim Hexal


Norway


3.3.2009




EU/1/08/496/001-008


Filgrastim Hexal


Liechtenstein


28.2.2009




EU/1/08/496/001-008/IS


Filgrastim Hexal


Iceland


20.3.2009




EU/1/08/497/001/NO


Nplate


Norway


2.3.2009




EU/1/08/497/001-002


Nplate (orphan)


Liechtenstein


28.2.2009




EU/1/08/497/001-002/IS


Nplate


Iceland


24.3.2009




EU/1/08/498/001/NO-008/NO


Thymanax


Norway


17.4.2009




EU/1/08/498/001-008


Thymanax


Liechtenstein


30.4.2009




EU/1/08/498/001-008/IS


Thymanax


Iceland


23.3.2009




EU/1/08/499/001/NO-008/NO


Valdoxan


Norway


16.4.2009




EU/1/08/499/001-008


Valdoxan


Liechtenstein


30.4.2009




EU/1/08/499/001-008/IS


Valdoxan


Iceland


23.3.2009




EU/1/08/500/001/NO-004/NO


Fablyn


Norway


24.3.2009




EU/1/08/500/001-004


Fablyn


Liechtenstein


30.4.2009




EU/1/08/500/001-004/IS


Fablyn


Iceland


24.4.2009




EU/1/08/501/001/NO-002/NO


Ixiaro


Norway


22.4.2009




EU/1/08/501/001-002


Ixiaro


Liechtenstein


30.4.2009




EU/1/08/501/001-002/IS


Ixiaro


Iceland


20.5.2009




EU/1/08/502/001


Mepact (orphan drug)


Liechtenstein


30.4.2009




EU/1/08/502/001/IS


Mepact


Iceland


19.5.2009




EU/1/08/502/001/NO


Mepact


Norway


12.5.2009




EU/1/08/503/001/NO-014/NO


Efient


Norway


1.4.2009




EU/1/08/503/001-014


Efient


Liechtenstein


30.4.2009




EU/1/08/503/001-014/IS


Efient


Iceland


3.3.2009




EU/1/08/504/001/NO-002/NO


Firmagon


Norway


12.3.2009




EU/1/08/504/001-002


Firmagon


Liechtenstein


28.2.2009




EU/1/08/504/001-002/IS


Firmagon


Iceland


13.3.2009




EU/1/08/505/001/NO-006/NO


Intanza


Norway


1.4.2009




EU/1/08/505/001-006


Intanza


Liechtenstein


30.4.2009




EU/1/08/505/001-006/IS


Intanza


Iceland


21.4.2009




EU/1/08/506/001


Celvapan


Liechtenstein


30.4.2009




EU/1/08/506/001/IS


Celvapan


Iceland


20.4.2009




EU/1/08/506/001/NO


Celvapan


Norway


23.3.2009




EU/1/08/507/001/NO-006/NO


Idflu


Norway


1.4.2009




EU/1/08/507/001-006


Idflu


Liechtenstein


30.4.2009




EU/1/08/507/001-006/IS


Idflu


Iceland


21.4.2009




EU/1/09/508/001/NO-009/NO


Synflorix


Norway


22.4.2009




EU/1/09/508/001-009


Synflorix


Liechtenstein


30.4.2009




EU/1/09/508/001-009/IS


Synflorix


Iceland


30.5.2009




EU/1/09/509/001/NO-004/NO


Ribavirin Teva


Norway


15.5.2009




EU/1/09/509/001-004


Ribavirin Teva


Liechtenstein


30.4.2009




EU/1/09/509/001-004/IS


Ribavirin Teva


Iceland


23.5.2009




EU/1/09/510/001/NO-019/NO


Fertavid


Norway


14.5.2009




EU/1/09/510/001-019


Fertavid


Liechtenstein


30.4.2009




EU/1/09/510/001-019/IS


Fertavid


Iceland


26.6.2009




EU/1/09/511/001/NO-004/NO


Conbriza


Norway


12.5.2009




EU/1/09/511/001-004


Conbriza


Liechtenstein


30.4.2009




EU/1/09/511/01-04/IS


Conbriza


Iceland


25.6.2009




EU/1/09/512/001/NO-002/NO


Removab


Norway


4.5.2009




EU/1/09/512/001-002


Removab


Liechtenstein


30.4.2009




EU/1/09/512/001-002/IS


Removab


Iceland


18.5.2009




EU/1/09/513/001/NO-020/NO


Rivastigmin Teva


Norway


5.5.2009




EU/1/09/513/001-020


Rivastigmin Teva


Liechtenstein


30.4.2009




EU/1/09/513/001-020/IS


Rivastigmin Teva


Iceland


2.6.2009




EU/1/09/514/001/NO-020/NO


Zebinix


Norway


27.5.2009




EU/1/09/514/001-020


Zebinix


Liechtenstein


30.4.2009




EU/1/09/514/001-020/IS


Zebinix


Iceland


30.5.2009




EU/1/09/515/001-004


Controloc Control


Liechtenstein


30.6.2009




EU/1/09/516/001-004


Somac Control


Liechtenstein


30.6.2009




EU/1/09/517/001-004


Pantozol Control


Liechtenstein


30.6.2009




EU/1/09/518/001-004


Pantecta


Liechtenstein


30.6.2009




EU/1/09/519/001-004


Pantoloc Control


Liechtenstein


30.6.2009




EU/1/09/520/001/NO-020/NO


Exalief


Norway


27.5.2009




EU/1/09/520/001-020


Exalief


Liechtenstein


30.4.2009




EU/1/09/520/001-020/IS


Exalief


Iceland


30.5.2009




EU/1/09/521/001-007


Renvela


Liechtenstein


30.6.2009




EU/1/09/522/001/IS


Ellaone


Iceland


22.6.2009




EU/1/09/522/001/NO


Ellaone


Norway


18.6.2009




EU/1/09/522/01


Ellaone


Liechtenstein


30.6.2009




EU/1/09/523/001-002


Modigraf


Liechtenstein


30.6.2009




EU/1/09/524/001


Qutenza


Liechtenstein


30.6.2009




EU/1/09/525/001-046


Nimvastid


Liechtenstein


30.6.2009




EU/1/09/525/001-046/IS


Nimvastid


Iceland


26.6.2009




EU/1/09/526/001


Iressa


Liechtenstein


30.6.2009




EU/1/8/491/001/NO-080/NO


Razilez HCT


Norway


19.2.2009




EU/107/440/001-002


Tyverb


Liechtenstein


30.4.2009




EU/108/462/001-012


Ranexa


Liechtenstein


30.4.2009




EU/2/06/067/001/NO-002/NO


Medisinsk oksygen


Norway


15.1.2009




EU/2/08/080/001/NO-004/NO


Reconcile


Norway


13.1.2009




EU/2/08/081/001/NO-003/NO


Posatex


Norway


13.1.2009




EU/2/08/082/001/NO-003/NO


Zactran


Norway


15.1.2009




EU/2/08/083/001/NO


Equioxx


Norway


4.2.2009




EU/2/08/085/001/IS


Easotic


Iceland


26.1.2009




EU/2/08/087/001/NO-002/NO


Masivet


Norway


5.1.2009




EU/2/08/088/001-004/IS


Acticam


Iceland


27.1.2009




EU/2/08/089/001/NO-020/NO


Onsior


Norway


19.1.2009




EU/2/08/089/001-020


Onsior


Liechtenstein


28.2.2009




EU/2/08/089/001-020/IS


Onsior


Iceland


25.1.2009




EU/2/08/090/001/NO-008/NO


Loxicom


Norway


13.3.2009




EU/2/08/090/001-008


Loxicom


Liechtenstein


28.2.2009




EU/2/08/091/001/NO-010/NO


Porcilis PCV


Norway


6.2.2009




EU/2/08/091/001-010


Porcilis PCV


Liechtenstein


28.2.2009




EU/2/08/091/001-010/IS


Porcilis PCV


Iceland


2.3.2009




EU/2/08/092/001/NO-007/NO


Startvac


Norway


16.3.2009




EU/2/08/092/001-007


Startvac


Liechtenstein


28.2.2009




EU/2/08/092/001-007/IS


Startvac


Iceland


24.3.2009




EU/2/09/093/001/NO-002/NO


Netvax


Norway


29.4.2009




EU/2/09/093/001-002


Netvax


Liechtenstein


30.4.2009




EU/2/09/093/001-002/IS


Netvax


Iceland


30.6.2009




EU/2/09/094/001/NO-005/NO


BTVPUR


Norway


11.5.2009




EU/2/09/094/001-005


BTVPUR


Liechtenstein


30.4.2009




EU/2/09/094/001-005/IS


BTVPUR


Iceland


28.5.2009




EU/2/09/095/001/NO-003/NO


Improvac


Norway


30.6.2009




EU/2/09/095/001-003


Improvac


Liechtenstein


30.6.2009







ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/03/263/001/NO-003/NO


Dukoral


Norway


27.5.2009




EU/1/03/263/001-003


Dukoral


Liechtenstein


30.4.2009




EU/1/03/263/001-003/IS


Dukoral


Iceland


24.4.2009




EU/1/03/264/001


Zevalin


Liechtenstein


28.2.2009




EU/1/03/264/001/IS


Zevalin


Iceland


22.2.2009




EU/1/03/265/003/NO-006/NO


Bonviva


Norway


17.4.2009




EU/1/03/265/003-006


Bonviva


Liechtenstein


30.4.2009




EU/1/03/265/003-006/IS


Bonviva


Iceland


16.4.2009




EU/1/03/266/003/NO-006/NO


Bondenza


Norway


17.4.2009




EU/1/03/266/003-006


Bondenza


Liechtenstein


30.4.2009




EU/1/03/266/003-006/IS


Bondenza


Iceland


16.4.2009




EU/1/03/267/001/NO-010/NO


Reyataz


Norway


15.4.2009




EU/1/03/267/001-010


Reyataz


Liechtenstein


30.4.2009




EU/1/03/267/001-010/IS


Reyataz


Iceland


8.4.2009




EU/1/03/268/001/NO-004/NO


Cholestagel


Norway


25.5.2009




EU/1/03/268/001-004


Cholestagel


Liechtenstein


30.4.2009




EU/1/03/268/001-004/IS


Cholestagel


Iceland


27.6.2009




EU/1/03/269/001/IS


Faslodex


Iceland


26.1.2009




EU/1/03/269/001/NO


Faslodex


Norway


3.3.2009




EU/1/03/270/001-003


Kentera


Liechtenstein


30.6.2009




EU/1/03/270/001-003/IS


Kentera


Iceland


24.6.2009




EU/1/03/271/001/NO-006/NO


Advate


Norway


14.4.2009




EU/1/03/271/001-006


Advate


Liechtenstein


30.4.2009




EU/1/03/271/001-006/IS


Advate


Iceland


27.5.2009




EU/1/04/272/001-002


PhotoBarr


Liechtenstein


30.4.2009




EU/1/04/272/001-002/IS


PhotoBarr


Iceland


28.4.2009




EU/1/04/273/001


Lysodren


Liechtenstein


30.4.2009




EU/1/04/273/001/IS


Lysodren


Iceland


28.5.2009




EU/1/04/273/001/NO


Lysodren


Norway


25.5.2009




EU/1/04/274/001/NO-002/NO


Velcade


Norway


5.6.2009




EU/1/04/274/001-002


Velcade


Liechtenstein


30.4.2009




EU/1/04/274/001-002/IS


Velcade


Iceland


29.6.2009




EU/1/04/275/001-002


Litak


Liechtenstein


30.4.2009




EU/1/04/275/002/IS


Litak


Iceland


25.6.2009




EU/1/04/276/001-020, 024-036


Abilify


Liechtenstein


30.6.2009




EU/1/04/277/001-004


TachoSil


Liechtenstein


30.6.2009




EU/1/04/278/001/NO-009/NO


Levemir


Norway


20.5.2009




EU/1/04/278/001-009


Levemir


Liechtenstein


30.4.2009




EU/1/04/278/001-009/IS


Levemir


Iceland


26.5.2009




EU/1/04/281/001-005


Erbitux


Liechtenstein


30.6.2009




EU/1/04/282/001-002


Telzir


Liechtenstein


30.6.2009




EU/1/04/283/008-012


Ariclaim


Liechtenstein


30.6.2009




EU/1/04/296/001-009


Cymbalta


Liechtenstein


30.6.2009




EU/1/04/297/001-008


Xeristar


Liechtenstein


30.6.2009




EU/1/06/367/001/NO-012/NO


Diacomit


Norway


5.1.2009




EU/1/06/380/001/IS


Prezista


Iceland


10.1.2009




EU/1/06/380/001/NO


Prezista


Norway


20.1.2009




EU/1/07/423/001-003


Vectibix


Liechtenstein


30.4.2009




EU/1/07/436/001/NO-002/NO


Isentress


Norway


24.2.2009




EU/1/07/440/001/NO-002/NO


Tyverb


Norway


18.6.2009




EU/1/07/440/001-002/IS


Tyverb


Iceland


25.5.2009




EU/1/98/089/001/NO-022/NO


Pritor


Norway


6.1.2009




EU/1/98/090/001/NO-020/NO


Micardis


Norway


6.1.2009




EU/1/98/091/001/NO-014/NO


Kinzalmono


Norway


6.1.2009




EU/1/98/095/001/NO-004/NO


Emadine


Norway


2.3.2009




EU/1/98/095/001-004


Emadine


Liechtenstein


28.2.2009




EU/1/98/095/001-004/IS


Emadine


Iceland


23.2.2009




EU/1/98/096/001/NO-012/NO


Temodal


Norway


5.2.2009




EU/1/98/096/001-012


Temodal


Liechtenstein


28.2.2009




EU/1/98/096/001-012/IS


Temodal


Iceland


16.1.2009




EU/1/99/097/001


Beromun


Liechtenstein


30.4.2009




EU/1/99/097/001/IS


Beromun


Iceland


19.5.2009




EU/1/99/097/001/NO


Beromun


Norway


4.6.2009




EU/1/99/099/001/NO-006/NO


Zerene


Norway


2.4.2009




EU/1/99/099/001-006


Zerene


Liechtenstein


30.4.2009




EU/1/99/099/001-006/IS


Zerene


Iceland


24.3.2009




EU/1/99/100/001/NO-003/NO


Cetrotide


Norway


25.5.2009




EU/1/99/100/001-003


Cetrotide


Liechtenstein


30.4.2009




EU/1/99/101/001


Regranex


Liechtenstein


30.4.2009




EU/1/99/101/001/IS


Regranex


Iceland


24.6.2009




EU/1/99/101/001/NO


Regranex


Norway


25.5.2009




EU/1/99/102/001/NO-006/NO


Sonata


Norway


2.4.2009




EU/1/99/102/001-006


Sonata


Liechtenstein


30.4.2009




EU/1/99/102/001-006/IS


Sonata


Iceland


24.3.2009




EU/1/99/103/001-004


ReFacto AF


Liechtenstein


30.4.2009




EU/1/99/107/001-005


Rebetol


Liechtenstein


30.4.2009




EU/1/99/107/001-005/IS


Rebetol


Iceland


2.6.2009




EU/1/99/110/001/NO-005/NO, 008/NO-010/NO


Sustiva


Norway


20.5.2009




EU/1/99/110/001-005&008-010/IS


Sustiva


Iceland


22.6.2009




EU/1/99/110/001-005, 008-009


Sustiva


Liechtenstein


30.4.2009




EU/1/99/111/001/NO-005/NO, 008/NO-011/NO


Stocrin


Norway


25.5.2009




EU/1/99/111/001-005&008-011/IS


Stocrin


Iceland


22.6.2009




EU/1/99/111/001-005, 008-011


Stocrin


Liechtenstein


30.4.2009




EU/1/99/112/001-002


Ziagen


Liechtenstein


30.6.2009




EU/1/99/119/001, 003, 005-015


NovoRapid


Liechtenstein


30.6.2009




EU/1/99/119/001/NO,-003/NO,-005/NO-015/NO


NovoRapid


Norway


16.6.2009




EU/2/03/041/001/NO-005/NO


Draxxin


Norway


21.1.2009




EU/2/04/042/001-006/IS


Novem


Iceland


14.5.2009




EU/2/04/042/005-006


Novem


Liechtenstein


30.4.2009




EU/2/04/043/001


Equilis StrepE


Liechtenstein


30.6.2009




EU/2/04/044/008


Aivlosin


Liechtenstein


30.4.2009




EU/2/04/045/001-007


Previcox


Liechtenstein


30.6.2009




EU/2/98/010/004-006,017-018,021-024


Econor


Liechtenstein


30.4.2009




EU/2/98/010/010/004-014&017-018&021-024/IS


Econor


Iceland


16.4.2009




EU/2/99/011/001/IS


Locatim


Iceland


25.1.2009




EU/2/99/011/001/NO


Locatim


Norway


6.2.2009







ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/00/133/009-032


Optisulin


Liechtenstein


30.4.2009




EU/1/00/155/007


Luveris


Liechtenstein


30.6.2009




EU/1/03/255/007-008


Ventavis


Liechtenstein


30.6.2009




EU/1/03/260/024/NO-033/NO


Stalevo


Norway


29.4.2009




EU/1/03/260/024-033/IS


Stalevo


Iceland


25.5.2009




EU/1/03/260/024-33


Stalevo


Liechtenstein


30.4.2009




EU/1/05/315/002


Aptivus


Liechtenstein


30.6.2009




EU/1/05/319/005/NO-010/NO


Xolair


Norway


12.5.2009




EU/1/05/319/005-010/IS


Xolair


Iceland


29.6.2009




EU/1/05/328/001-002/IS


Cubicin


Iceland


3.6.2009




EU/1/06/347/007-008


Sutent


Liechtenstein


30.6.2009




EU/1/06/363/010/NO-011/NO


Sprycel


Norway


11.2.2009




EU/1/06/363/010-011


Sprycel


Liechtenstein


28.2.2009




EU/1/06/363/010-011/IS


Sprycel


Iceland


22.2.2009




EU/1/06/368/143/NO-162/NO


Insulin Human Winthrop


Norway


15.4.2009




EU/1/06/368/143-162


Insulin Human Winthrop


Liechtenstein


28.2.2009




EU/1/06/368/143-162/IS


Insulin Human Winthrop


Iceland


22.4.2009




EU/1/06/368/163-168


Insulin Human Winthrop


Liechtenstein


30.6.2009




EU/1/06/370/034-036


Exforge


Liechtenstein


30.4.2009




EU/1/06/371/034-036


Dafiro


Liechtenstein


30.4.2009




EU/1/06/372/034-036


Copalia


Liechtenstein


30.4.2009




EU/1/06/373/034-036


Imprida


Liechtenstein


30.4.2009




EU/1/06/380/002/NO-003/NO


Prezista


Norway


24.2.2009




EU/1/06/380/002-003


Prezista


Liechtenstein


28.2.2009




EU/1/06/380/002-003/IS


Prezista


Iceland


13.5.2009




EU/1/06/380/004-005


Prezista


Liechtenstein


30.6.2009




EU/1/07/387/011/NO-013/NO


Advagraf


Norway


4.6.2009




EU/1/07/387/011-013


Advagraf


Liechtenstein


30.4.2009




EU/1/07/387/011-013/IS


Advagraf


Iceland


24.6.2009




EU/1/07/388/003


Sebivo


Liechtenstein


28.2.2009




EU/1/07/388/003/IS


Sebivo


Iceland


20.3.2009




EU/1/07/388/003/NO


Sebivo


Norway


14.5.2009




EU/1/07/395/065-095


Invega


Liechtenstein


28.2.2009




EU/1/07/395/077/NO-095/NO


Invega


Norway


5.3.2009




EU/1/07/395/077-095/IS


Invega


Iceland


27.2.2009




EU/1/07/401/007/NO-010/NO


Alli


Norway


12.2.2009




EU/1/07/401/007-010


Alli


Liechtenstein


28.2.2009




EU/1/07/401/007-010/IS


Alli


Iceland


19.3.2009




EU/1/08/446/004


Privigen


Liechtenstein


30.6.2009




EU/1/08/454/005


Extavia


Liechtenstein


30.4.2009




EU/1/08/455/015-016


Janumet


Liechtenstein


30.6.2009




EU/1/08/456/015-016


Velmetia


Liechtenstein


30.6.2009




EU/1/08/457/015-016


Efficib


Liechtenstein


30.6.2009




EU/1/08/458/012-014


Trevaclyn


Liechtenstein


30.6.2009




EU/1/08/459/012-014


Tredaptive


Liechtenstein


30.6.2009




EU/1/08/460/012-014


Pelzont


Liechtenstein


30.6.2009




EU/1/08/464/018-019


Clopidogrel BMS


Liechtenstein


28.2.2009




EU/1/08/465/018-019


Clopidogrel Winthrop


Liechtenstein


28.2.2009




EU/1/97/030/170/NO-189/NO


Insuman


Norway


8.4.2009




EU/1/97/030/170-189


Insuman


Liechtenstein


30.4.2009




EU/1/97/030/170-189/IS


Insuman


Iceland


22.4.2009




EU/1/97/030/190-195


Insuman


Liechtenstein


30.6.2009




EU/1/97/055/004


Viramune


Liechtenstein


30.6.2009




EU/1/98/063/008/NO-10/NO


Rebif


Norway


9.2.2009




EU/1/98/063/008-010


Rebif


Liechtenstein


28.2.2009




EU/1/98/063/008-010/IS


Rebif


Iceland


18.3.2009




EU/1/98/069/011a-011b


Plavix


Liechtenstein


28.2.2009




EU/1/98/070/011a-011b


Iscover


Liechtenstein


28.2.2009




EU/1/98/096/013-023


Temodal


Liechtenstein


28.2.2009




EU/1/98/096/023/IS


Temodal


Iceland


24.3.2009




EU/1/98/096/023/NO


Temodal


Norway


18.3.2009




EU/1/99/110/010


Sustiva


Liechtenstein


30.4.2009




EU/1/99/116/004-005


Remicade


Liechtenstein


30.4.2009




EU/1/99/123/013


Renagel


Liechtenstein


30.6.2009




EU/2/04/044/009-010


Aivlosin


Liechtenstein


30.6.2009




EU/2/06/058/004/IS


Flexicam


Iceland


27.1.2009




EU/2/07/078/004


Rheumocam


Liechtenstein


30.6.2009







ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2009:








EU-Number


Product


Country


Date of withdrawal




EU/1/01/184/001/NO-073/NO


Nespo


Norway


11.3.2009




EU/1/01/184/001-073/IS


Nespo


Iceland


24.1.2009




EU/1/01/211/001/NO-012/NO


Dynepo


Norway


18.5.2009




EU/1/02/211/001-005&010-012/IS


Dynepo


Iceland


14.4.2009




EU/1/02/211/001-005,010-012


Dynepo


Liechtenstein


30.4.2009




EU/1/02/228/001-003/IS


Neupopeg


Iceland


24.1.2009




EU/1/02/232/001-003


Velosulin


Liechtenstein


28.2.2009




EU/1/02/232/001-003/IS


Velosulin


Iceland


18.3.2009




EU/1/04/291/001-003


Raptiva


Liechtenstein


30.6.2009




EU/1/04/291/001-003/IS


Raptiva


Iceland


27.4.2009




EU/1/04/293/001/NO-012/NO


Parareg


Norway


12.3.2009




EU/1/04/293/001-012/IS


Parareg


Iceland


23.1.2009




EU/1/06/344/001/NO-011/NO


Acomplia


Norway


11.3.2009




EU/1/06/344/001-011


Acomplia


Liechtenstein


28.2.2009




EU/1/06/344/001-011/IS


Acomplia


Iceland


23.1.2009




EU/1/06/345/001/NO-011/NO


Zimulti


Norway


13.2.2009




EU/1/06/345/001-011


Zimulti


Liechtenstein


28.2.2009




EU/1/06/345/001-011/IS


Zimulti


Iceland


23.1.2009




EU/1/99/102/007/NO-008/NO


Sonata


Norway


2.4.2009




EU/1/99/110/006/NO-007/NO


Sustiva


Norway


20.5.2009




EU/1/99/111/006/NO-007/NO


Stocrin


Norway


25.5.2009







ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2009:








EU-Number


Product


Country


Date of suspension




EU/1/042/291/001-003


Raptiva


Liechtenstein


30.4.2009




EU/1/05/326/001


Ionsys


Liechtenstein


28.2.2009




EU/1/05/326/001/IS


Ionsys


Iceland


23.1.2009




EU/2/99/016/001-006


Porcilis Pesti


Liechtenstein


28.2.2009




EU/2/99/016/001-006/IS


Porcilis Pesti


Iceland


24.3.2009